We are live on ! Find out more
CDH

Charles D. Hyman Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$1.6B
AUM Growth
+$97.4M
Cap. Flow
+$3.5M
Cap. Flow %
0.22%
Top 10 Hldgs %
38.98%
Holding
247
New
5
Increased
46
Reduced
69
Closed
11

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$6.83M
2
ABBV icon
AbbVie
ABBV
+$2.22M
3
FCX icon
Freeport-McMoran
FCX
+$1.63M
4
VZ icon
Verizon
VZ
+$531K
5
SDS icon
ProShares UltraShort S&P500
SDS
+$501K

Sector Composition

Rank Sector Weight
1 Technology 17.91%
2 Industrials 15.56%
3 Financials 15.11%
4 Consumer Staples 10.06%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXC icon
226
Exelon
EXC
$48.4B
$224K 0.01%
5,500
GWW icon
227
W.W. Grainger
GWW
$66B
$213K 0.01%
+270
New +$186K
XLK icon
228
State Street Technology Select Sector SPDR ETF
XLK
$112B
$205K 0.01%
+2,362
New +$186K
XLU icon
229
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$203K 0.01%
6,214
IWF icon
230
iShares Russell 1000 Growth ETF
IWF
$119B
$201K 0.01%
2,916
-800
-22% -$50.9K
IYZ icon
231
iShares US Telecommunications ETF
IYZ
$1.19B
$201K 0.01%
9,100
CHI
232
Calamos Convertible Opportunities and Income Fund
CHI
$994M
$185K 0.01%
16,500
MPT
233
Medical Properties Trust
MPT
$2.89B
$168K 0.01%
18,123
XXII
234
22nd Century Group
XXII
$1.36M
0
MTNB icon
235
Matinas BioPharma
MTNB
$1.88M
$29K ﹤0.01%
1,596
LMDX
236
DELISTED
LumiraDx Limited Common Shares
LMDX
$14K ﹤0.01%
30,000
ABCB icon
237
Ameris Bancorp
ABCB
$5.9B
-5,644
Closed -$206K
C icon
238
Citigroup
C
$222B
-4,553
Closed -$213K
CCI icon
239
Crown Castle
CCI
$33.1B
-1,718
Closed -$230K
CPB icon
240
Campbell Soup
CPB
$6.8B
-3,800
Closed -$209K
GPN icon
241
Global Payments
GPN
$23.9B
-1,961
Closed -$206K
LUMN icon
242
Lumen
LUMN
$6.38B
-13,400
Closed -$36K
MDT icon
243
Medtronic
MDT
$111B
-2,888
Closed -$233K
MRNA icon
244
Moderna
MRNA
$22.1B
-1,475
Closed -$227K
PYPL icon
245
PayPal
PYPL
$50.3B
-89,963
Closed -$6.83M
RVTY icon
246
Revvity
RVTY
$12.4B
-1,558
Closed -$208K
SDS icon
247
ProShares UltraShort S&P500
SDS
$422M
-2,505
Closed -$501K

Similar funds

Charles D. Hyman's Q2 2023 Portfolio in Review

As of Q2 2023, Charles D. Hyman held 247 positions worth $1.6B, up 6.5% from $1.5B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Charles D. Hyman's Q2 2023 filing shows 5 new, 46 increased, 69 reduced and 11 closed positions. Its largest new stake was Intuitive Surgical: 7,670 shares worth $2.62M. The largest sale was PayPal, an estimated $6.83M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

  • Charles D. Hyman's largest Q2 2023 buy was Intuitive Surgical: 7,670 shares worth $2.62M.
  • Charles D. Hyman added most to Mastercard in Q2 2023, an estimated $5.48M increase.
  • Charles D. Hyman's biggest Q2 2023 reduction was AbbVie, cutting an estimated $2.22M.
  • Charles D. Hyman fully exited PayPal in Q2 2023, selling an estimated $6.83M.
  • Charles D. Hyman's ten largest holdings make up 39% of its $1.6B portfolio in Q2 2023.
  • Charles D. Hyman opened 5 new positions and closed 11 in Q2 2023.
  • Charles D. Hyman's portfolio value rose 6.5% quarter-over-quarter to $1.6B.

Based on Charles D. Hyman's 13F filing for Q2 2023, filed 8 Aug 2023.